As part of the initiative, cultured avian fat biomass will provide the signature flavors, aromas, and textures of conventional meat while Enough’s mycoprotein will add high nutritional value with protein and fiber content and essential amino acids, zinc and iron.
MeaTech (Rehovat, Israel), and food company at the forefront of the cultured meat industry, has announced that its wholly owned Belgian subsidiary, Peace of Meat, has signed a joint development agreement with Enough, a leader in the field of mycoprotein, a fungi-based fermented food ingredient. The aim of the collaboration is to accelerate MeaTech’s go-to-market strategy for hybrid products.
The initiative will combine Peace of Meat’s unique expertise in cultured avian development with Enough’s cutting-edge mycoprotein ingredient to create hybrid alternative meat products. More specifically, cultured avian fat biomass will provide the signature flavors, aromas, and textures of conventional meat while Enough’s mycoprotein will add high nutritional value with protein and fiber content and essential amino acids, zinc and iron.
“We believe that the future of sustainable protein will include a mix of plant- fermentation- and cell-based products. Therefore, we are delighted to combine our fermented biomass with the cultured chicken fat biomass being developed by MeaTech’s subsidiary, Peace of Meat,” said Jim Laird, CEO of Enough.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.